• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » FDA clears DePuy Synthes TriLeap plating system for foot and ankle surgeries

FDA clears DePuy Synthes TriLeap plating system for foot and ankle surgeries

October 13, 2023 By Chris Newmarker

This marketing illustration from Johnson & Johnson DePuy Synthes shows various components of the TriLeap lower extremity anatomic plating system that are arrayed around a drawing of bones in the human foot and ankle.
The TriLeap lower extremity anatomic plating system [Image courtesy of DePuy Synthes]
DePuy Synthes, the orthopedic device business of Johnson & Johnson (NYSE: JNJ) , has won FDA 510(k) clearance for its TriLeap lower extremity anatomic plating system.

The company said it designed the TriLeap system to address the intricate needs of orthopedic surgeons and foot and ankle specialists.

As conditions like bunions become more prevalent —with Cleveland Clinic reporting that one in three U.S. residents are grappling with the disorder—elective foot surgeries are witnessing a surge. Plating systems like TriLeap play an important role in these surgeries, functioning as implants that stabilize the bones during procedures such as bunionectomies and osteotomies.

TriLeap offers a wide range of plate options tailored for various procedures and screw diameters, according to DePuy Synthes. Its instruments can be used during the reduction, internal fixation and fusion of bones and bone fragments.

“As a leader in elective foot and ankle procedures, DePuy Synthes is dedicated to developing novel solutions tailored to the changing needs of both patients and surgeons,” said Oray Boston, worldwide president of DePuy Synthes Trauma, Extremities, Craniomaxillofacial, Animal Health and Sports.

Boston added in the news release that, “The development and clearance of the TriLeap lower extremity anatomic plating system is a prime example of how we are maintaining our speed of innovation in the space to address unmet needs and help achieve the best possible outcomes for patients.”

DePuy Synthes anticipates launching TriLeap in the U.S. next year.

Products and services at DePuy Synthes support joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery and sports medicine — in addition to the Velys digital surgery portfolio.

Filed Under: 510(k), Food & Drug Administration (FDA), News Well, Orthopedic Implants, Orthopedics, Regulatory/Compliance Tagged With: DePuy Synthes, Johnson & Johnson

More recent news

  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • GE HealthCare taps retiring AT&T CFO for board of directors
  • Corcym delivers first-in-human implant of Memo 4D Curve mitral repair ring
  • Boston Scientific MedSurg, Asia Pacific leader to retire
  • DePuy Synthes launches next-generation automated fracture fixation system

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy